KELLEYAYN WALLACE: Open Payments
NPI 1831290717 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,933 in 96 payments from 20 companies in 2025. Trend: 2023 $471 · 2024 $1,637 · 2025 $1,933
Food & beverage: $1,913Education: $20
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $494 |
| ABBVIE INC. | 17 | $279 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $225 |
| Lilly USA, LLC | 3 | $151 |
| Phathom Pharmaceuticals, Inc. | 4 | $92 |
| Ipsen Biopharmaceuticals, Inc | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Novo Nordisk Inc | 3 | $68 |
| Ferring Pharmaceuticals Inc. | 2 | $66 |
| Exact Sciences Corporation | 3 | $62 |
Products named: TREMFYA, RINVOQ, XIFAXAN, OMVOH, DUPIXENT, VOQUEZNA, IQIRVO, ENTYVIO.
Industry payments across NY — which companies pay providers there.
